Connect with us
Researchers grouped 4,600 patients into five subtypes. Some are driven by genes rather than weight, and may carry higher risk. The findings still need confirming.
Columbia researchers link a rare FN1 gene change to a healthier blood-brain barrier in carriers of the APOE4 risk gene. It's a target, not a treatment.
